Menu visibility control

Video

Events

Startup Surgery

Most Recent

News

Top tech stats: Job automation, driverless cars and much more

News

Startup Weekly: Nesta’s £5m prize fund, Digital Catapult and Seedcamp’s VR cohort and much more

Investments

FinTech startup Quantexa lands $3.3m Series A led by Albion Ventures and HSBC

Press Releases

Starling Bank unveils beta as it begins roll out to first customers
VentureFounders surpasses £40m funding mark in 2 years of operation
Software testing leader TestPlant appoints Dr. John Bates as CEO

Geneix helps doctors find better treatment – Startup of the week

twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Welcome to the sixth episode of the Elevator Pitch series 4.

Every week we publish a 30 second pitch from the latest intake of the Elevator Pitch. These leading startups join an alumni group that includes the likes of YPlan, Hassle, import.io and Glow, and has to-date raised over $36m.

In this series we took the founders on a cab ride unlike any other for the most exciting pitch of their lives.

HealthTech startup MedShr lands over £1.5m to help doctors share expertise

Geneix helps doctors use patients’ DNA data to find better treatments.

They take the vast amount of evidence on how genetic variation affects the response of different medications, and use it to inform decisions on a patient-by-patient basis.

This makes prescribing drugs easier, reducing the trial-and-error problem doctors have when finding the right treatment.

One size doesn’t fit all

Founder Mark Bartlett came up with the idea when studying genetics at University College London.

He noticed that although there’s so much evidence linking genes and medication, this information is not used when prescribing.

So in 2012 Bartlett set up Geneix to speed up the process of translating that data for the benefit of patients.

The software helps doctors identify people who are unlikely to respond to a treatment, and help them choose one that’s more appropriate.

We’re solving the ‘one-size-fits-all’ approach to prescribing.

Building the ecosystem

Bartlett says the market is relatively new in the UK, although the different healthcare systems in the US mean there is more traction across the pond.

However, 100,000 Brits are having their genome sequenced by 2017 due to Genomics England – expected to be the largest genetic database in the world.

Bartlett says this represents a developing ecosystem for Geneix’s solutions.

Growth and validation

A grant from Innovate UK‘s IC tomorrow programme and a place on Wayra UK have helped the company grow, but Bartlett says getting the support from stakeholders such as the NHS and laboratories has been very rewarding.

When we started most people we met would only feedback that we are too early and using genetics to guide prescribing will not happen for at least 10 years.

This is changing and is creating an extremely exciting environment to operate.

Bartlett hopes to sign up two hospital partners in the coming months to help validate Geneix’s products.

The company’s latest product will be ready to go to market next year.

Enter your e-mail address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

jobs automation top tech stats

Top tech stats: Job automation, driverless cars and much more
posted 6 hours ago

Startup Weekly

Startup Weekly: Nesta’s £5m prize fund, Digital Catapult and Seedcamp’s VR cohort and much more
posted on March 24, 2017

London skyline

FinTech startup Quantexa lands $3.3m Series A led by Albion Ventures and HSBC
posted on March 24, 2017

The North of England

The top tech hubs in the North of England
posted on March 24, 2017

TWIT Emily 23.03.17

A $30.4m Series B, a £120m AI fund, a Mario Kart hack and more in The Week in Tech
posted on March 24, 2017

Tech and banking

How tech is shaking up the world of banking
posted on March 23, 2017